Youth & Soul review

Youth & Soul gets the compliance basics right: its compounded line carries no FDA-approved badge, a LegitScript seal with a checkable certificate number sits alongside a Trust & Compliance page, and Bask Health is named as the clinician network. Credit where it is due. The catch is the commercial shape, and it is why there is no single price to quote. Peptides here exist only inside stacked tiers — $149 a month buys sermorelin/ipamorelin plus sublingual NAD⁺ plus methylene blue plus a hormone panel; $299 adds injectable or nasal NAD⁺, BPC-157 and low-dose naltrexone. No molecule has its own price, and three or four at once is a lot to start simultaneously.

Youth & Soul is a multi-vertical longevity marketplace selling doctor-prescribed telehealth programs across eight or more categories — weight loss, menopause and HRT, sexual health, longevity, skin and hair, brain, gut health and mental health — each priced as tiered protocol bundles rather than as individual drugs. Its Longevity & Vitality program runs three tiers: Cellular Defense at $99/mo (methylene blue and metformin), Growth Hormone Optimization at $149/mo (sermorelin/ipamorelin injections, sublingual NAD⁺ 250 mg, methylene blue, and an IGF-1 and hormone panel review) and Ultimate Longevity Protocol at $299/mo (sermorelin/ipamorelin, injectable or nasal NAD⁺ 500 mg, BPC-157, low-dose naltrexone, methylene blue and a longevity blood panel). BPC-157 also appears inside its pain and gut tiers.

Asynchronous intake into a bundled program, with the clinical layer outsourced to a named network. Its disclosures state that the on-site assessment does not establish a doctor-patient relationship, that Bask Health — described as a network of US-licensed physicians — sets the exclusionary criteria and conducts a consultation after checkout, and that all prescribing decisions rest with the treating clinician. Compounded medications are stated to be prepared by a US-licensed 503A pharmacy, which is not named. Its compliance signals are real and worth stating: a LegitScript seal with certificate number 51182633 is displayed with a link to the public checker and a dedicated Trust & Compliance page, and the only FDA-approved labels on the site sit on brand Wegovy and Ozempic pens, which genuinely are approved, not on the compounded line. Three marketing problems are worth weighing. The trust strip presenting large user and order counts is labeled "Powered by Bask Health" and its own affiliate page describes those totals as spanning the vendor's entire backend across all its clients, not this brand. The testimonial marquee carries a footnote stating it takes reviews "from across the internet" while the adjacent copy promises never to fabricate results — those two statements sit badly together. And the how-it-works step copy runs a scarcity line, "Currently 3 Telemed Doctor Consultations Available Today". No operating entity is named anywhere on the site.

Published per tier and never per molecule, so there is no single-molecule price to compare. The Longevity program's middle tier is $149 a month and its listed contents are sermorelin/ipamorelin peptide injections, NAD⁺ sublingual tablets at 250 mg, methylene blue, an IGF-1 and hormone panel blood work review, physician monitoring with dose optimization, sleep and recovery tracking and free shipping. The top tier is $299 a month and swaps the sublingual NAD⁺ for injectable or nasal NAD⁺ at 500 mg while adding BPC-157, low-dose naltrexone 1.5–4.5 mg, a comprehensive longevity blood panel, weekly physician check-ins and a biological-age assessment. The entry tier at $99 contains no peptide and no NAD⁺ at all — just methylene blue and metformin — so it is not an option if you want a peptide or NAD⁺. Stating milligram strengths inside a bundle is better practice than most competitors manage, and the tiers do include blood work, which many peptide sellers skip entirely. But $149 is not a sermorelin price and $299 is not an NAD⁺ price, and treating either as one would misrepresent both to anyone comparing against a single-molecule seller. Its state coverage claim — ships to all 50 states — appears inside a comparison table against named competitors rather than as an enumerated list.

Compounded; not FDA-approved, alongside a branded line where the approval claim is legitimate. Prescription required only if a licensed clinician finds it appropriate, with Bask Health named as the prescribing network and a US-licensed 503A pharmacy stated but not named. Compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, the bundling is the problem this section has to flag, because a tier starts several therapies at once and you will not know which one did anything. Sermorelin and ipamorelin act on the growth-hormone axis — real mechanisms, thin long-term human outcome data. Sublingual, injected and intranasal NAD⁺ all lack controlled human outcome trials; the oral precursors NR and NMN are the studied forms and raise a blood level rather than demonstrate a benefit. BPC-157 has no controlled human outcome trials at all; its tissue-repair reputation rests on rodent work. Methylene blue is an approved drug for methemoglobinemia being sold here for mitochondrial and cognitive claims that have no controlled human outcome trials behind them, and it interacts seriously with serotonergic medications including SSRIs — raise every medication and supplement you take at intake, because it appears in all three longevity tiers. Low-dose naltrexone is an off-label use of an approved molecule with limited controlled data. Individual results vary.